Loading clinical trials...
Loading clinical trials...
To evaluate the efficacy of early intervention (dosing within 2 hours of onset of the migraine attack) with eletriptan 40mg on mild versus moderate to severe pain intensity of migraine.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
NCT06810505 · Chronic Migraine
NCT06241313 · Migraine
NCT07018713 · Chronic Migraine
NCT07454798 · Migraine, Headache Disorders, Primary
NCT06735833 · Migraine
Pfizer Investigational Site
Edmonton, Alberta
Pfizer Investigational Site
Chilliwack, British Columbia
Pfizer Investigational Site
Coquitlam, British Columbia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions